| Literature DB >> 34830402 |
Mariona Jové1, Rosanna Cabré1, Natàlia Mota-Martorell1, Meritxell Martin-Garí1, Èlia Obis1, Paula Ramos1, Iván Canales1, José Daniel Galo-Licona1, Joaquim Sol1,2,3, Lara Nogueras1, Pascual Torres1, Manuel Portero-Otín1, Victòria Ayala1, Isidro Ferrer4,5, Reinald Pamplona1.
Abstract
Lipids are closely associated with brain structure and function. However, the potential changes in the lipidome induced by aging remain to be elucidated. In this study, we used chromatographic techniques and a mass spectrometry-based approach to evaluate age-associated changes in the lipidome of the frontal cortex and cerebellum obtained from adult male Wistar rats (8 months), aged male Wistar rats (26 months), and aged male Wistar rats submitted to a methionine restriction diet (MetR)-as an anti-aging intervention-for 8 weeks. The outcomes revealed that only small changes (about 10%) were observed in the lipidome profile in the cerebellum and frontal cortex during aging, and these changes differed, in some cases, between regions. Furthermore, a MetR diet partially reversed the effects of the aging process. Remarkably, the most affected lipid classes were ether-triacylglycerols, diacylglycerols, phosphatidylethanolamine N-methylated, plasmalogens, ceramides, and cholesterol esters. When the fatty acid profile was analyzed, we observed that the frontal cortex is highly preserved during aging and maintained under MetR, whereas in the cerebellum minor changes (increased monounsaturated and decreased polyunsaturated contents) were observed and not reversed by MetR. We conclude that the rat cerebellum and frontal cortex have efficient mechanisms to preserve the lipid profile of their cell membranes throughout their adult lifespan in order to maintain brain structure and function. A part of the small changes that take place during aging can be reversed with a MetR diet applied in old age.Entities:
Keywords: (lip)oxidation-derived protein damage markers; aging; glycerolipids; glycerophospholipids; mass spectrometry; methionine restriction; sphingolipids; sterol lipids
Mesh:
Substances:
Year: 2021 PMID: 34830402 PMCID: PMC8623997 DOI: 10.3390/ijms222212517
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Multivariate analysis of the differential lipid species detected in the cerebellum during aging and methionine restriction applied in old age. (A) Two-dimensional principal component analysis (PCA) for the different analyzed groups: adult, aged, and aged+MetR. (B) Heatmap of hierarchical clustering using the 25 lipid species with the lowest p-values. Each colored cell on the map corresponds to a relative concentration value, with samples in columns and compounds in rows. n (Adult) = 7, n (Aged) = 9, n (Aged+MetR) = 10.
Lipid species significantly different between experimental groups in the rat cerebellum.
| Class | ID | Post Hoc | Biological Meaning |
|---|---|---|---|
| GL | TG (52:0) a | A < R | |
| TG (47:0) b | A < R | ||
| TG-O (54:1) b | Ag, R < A | aging | |
| TG-O (60:1) b | Ag, R < A | aging | |
| TG-O (47:0) b | A, Ag < R | MetR | |
| TG-O (56:1) b | Ag < R, A | healthy aging | |
| GP | PS (36:1) a | A < R | |
| PE-P (38:4) a | A < R | ||
| PG-P (38:5) b | A < Ag, R | aging | |
| PE-P (40:4)/PE-O (40:5) a | Ag, R < A | aging | |
| PA (44:7) a | A < Ag, R | aging | |
| PE-Nme (36:6) b | A < Ag, R | aging | |
| PC-O (38:4)/PC-P (38:3) b | A < Ag, R | aging | |
| PE-Nme (34:3)/PE-NMe2 (33:3)/PC (32:3)/PE (35:3) b | A, Ag < R | MetR | |
| PC (36:4)/PC-O (35:4) a | A, Ag < R | MetR | |
| PS (40:4) a | Ag < R, A | healthy aging | |
| SP | Cer (34:1) a | Ag < R, A | healthy aging |
| Cer (38:4) a | A < Ag, R | aging | |
| SM (33:1) b | A < Ag, R | aging | |
| Ganglioside GA2 (44:1) b | Ag, R < A | aging | |
| N-(2R-Hydroxyhexadecanoyl)-2S-amino-9-methyl-4E,8E-octadecadiene-1,3R-diol b | A < Ag, R | aging | |
| SL | CE (22:4) b | Ag, R < A | aging |
| cholest-5-en-3b-yl (11Z,14Z-eicosadienoate) c | A, Ag < R | MetR | |
| CE (xx) | Ag < R, A | healthy aging |
All compounds are putatively annotated compounds based upon physicochemical properties and/or spectral similarity with public/commercial spectral libraries [29]. a Identity (ID) based on exact mass, retention time (RT), and MS/MS spectrum; b ID based on exact mass and RT; c ID based on MS/MS spectrum. CE (xx): specific cholesteryl ester species could not be annotated, but its MS/MS spectrum displayed a CE characteristic pattern. GL: glycerolipids, GP: glycerophospholipids, SP: sphingolipids, SL: sterol lipids. Ag: Aged, R: Aged+MetR, A: Adult, n.i: no information. n (Adult) = 7, n (Aged) = 9, n (Aged+MetR) = 10.
Fatty acid composition of total lipids in the rat cerebellum [30].
| Fatty Acid | Adult | Aged | Aged+MetR |
|---|---|---|---|
| 14:0 | 0.26 ± 0.00 | 0.29 ± 0.01 a,* | 0.32 ± 0.01 a,*** |
| 16:0 | 17.93 ± 0.16 | 18.00 ± 0.04 | 17.83 ± 0.14 |
| 16:1n-7 | 0.38 ± 0.01 | 0.41 ± 0.02 | 0.40 ± 0.01 |
| 18:0 | 17.63 ± 0.06 | 17.70 ± 0.09 | 17.66 ± 0.08 |
| 18:1n-9 | 26.00 ± 0.14 | 26.53 ± 0.25 | 26.74 ± 0.21 a,* |
| 18:2n-6 | 1.14 ± 0.02 | 1.19 ± 0.04 | 1.37 ± 0.05 a,***; b,** |
| 18:3n-6 | 0.02 ± 0.00 | 0.02 ± 0.00 | 0.01 ± 0.00 |
| 18:3n-3 | 0.02 ± 0.00 | 0.02 ± 0.00 | 0.01 ± 0.00 a,* |
| 18:4n-3 | 0.03 ± 0.00 | 0.03 ± 0.00 | 0.03 ± 0.00 |
| 20:0 | 0.70 ± 0.04 | 0.83 ± 0.01 a,* | 0.79 ± 0.04 |
| 20:1n-9 | 4.06 ± 0.14 | 4.48 ± 0.07 a,* | 4.49 ± 0.10 a,* |
| 20:2n-6 | 0.33 ± 0.01 | 0.29 ± 0.01 a,** | 0.30 ± 0.01 |
| 20:3n-6 | 0.31 ± 0.01 | 0.30 ± 0.01 | 0.32 ± 0.01 |
| 20:4n-6 | 7.69 ± 0.08 | 7.27 ± 0.09 a,** | 7.36 ± 0.09 a,* |
| 20:5n-3 | 0.04 ± 0.00 | 0.04 ± 0.00 a,* | 0.04 ± 0.00 |
| 22:0 | 0.74 ± 0.02 | 0.75 ± 0.01 | 0.76 ± 0.02 |
| 22:1n-9 | 1.08 ± 0.09 | 1.01 ± 0.02 | 1.03 ± 0.03 |
| 22:4n-6 | 2.60 ± 0.03 | 2.22 ± 0.05 a,*** | 2.22 ± 0.05 a,*** |
| 22:5n-6 | 0.43 ± 0.03 | 0.45 ± 0.03 | 0.41 ± 0.03 |
| 22:5n-3 | 0.14 ± 0.00 | 0.14 ± 0.01 | 0.12 ± 0.00 |
| 22:6n-3 | 13.43 ± 0.12 | 12.96 ± 0.14 | 12.89 ± 0.17 a,* |
| 24:0 | 1.11 ± 0.05 | 1.00 ± 0.02 | 1.03 ± 0.02 |
| 24:1 | 2.26 ± 0.05 | 2.54 ± 0.10 | 2.41 ± 0.08 |
| 24:5n-3 | 0.04 ± 0.00 | 0.04 ± 0.00 | 0.04 ± 0.00 |
| 24:6n-3 | 1.31 ± 0.04 | 1.38 ± 0.03 | 1.45 ± 0.03 a,* |
Data are expressed as mean ± SEM. a Comparison between aged and aged+MetR with the adult group; b comparison between aged and aged+MetR groups. * p < 0.05. ** p < 0.01. *** p < 0.001. n (Adult) = 8, n (Aged) = 8, n (Aged+MetR) = 8.
Calculated fatty acid indices from the fatty acid profile in the rat cerebellum.
| Fatty Acid Index | Adult | Aged | Aged+MetR |
|---|---|---|---|
| ACL | 18.91 ± 0.01 | 18.75 ± 0.08 | 18.89 ± 0.00 |
| SFA | 38.37 ± 0.17 | 38.35 ± 0.16 | 38.24 ± 0.14 |
| UFA | 61.52 ± 0.15 | 61.41 ± 0.12 | 61.58 ± 0.20 |
| MUFA | 33.64 ± 0.35 | 35.27 ± 0.16 a,** | 35.01 ± 0.33 a,** |
| PUFA | 27.53 ± 0.19 | 26.05 ± 0.19 a,*** | 26.57 ± 0.16 a,** |
| PUFAn-3 | 15.00 ± 0.10 | 14.59 ± 0.16 | 14.58 ± 0.15 |
| PUFAn-6 | 12.53 ± 0.12 | 11.65 ± 0.12 a,*** | 11.99 ± 0.15 a,* |
| DBI | 170.56 ± 0.96 | 165.22 ± 0.86 a,*** | 166.91 ± 0.64 a,* |
| PI | 166.05 ± 1.14 | 158.66 ± 1.08 a,*** | 160.06 ± 1.27 a,** |
| D9D (n-7) | 0.02 ± 0.00 | 0.02 ± 0.00 | 0.02 ± 0.00 |
| D9D (n-9) | 1.47 ± 0.01 | 1.50 ± 0.02 | 1.51 ± 0.02 |
| D5D (n-6) | 24.65 ± 0.42 | 24.45 ± 0.73 | 23.36 ± 0.63 |
| D6D (n-3) (a) | 1.84 ± 0.05 | 1.83 ± 0.08 | 1.99 ± 0.09 |
| D6D (n-3) (b) | 31.22 ± 1.76 | 34.49 ± 1.58 | 36.78 ± 1.87 |
| Elovl3 (n-9) | 0.16 ± 0.01 | 0.17 ± 0.00 | 0.17 ± 0.00 |
| Elovl6 | 0.98 ± 0.01 | 0.98 ± 0.00 | 0.99 ± 0.01 |
| Elovl1-3-7 (a) | 0.04 ± 0.00 | 0.05 ± 0.00 a,* | 0.04 ± 0.00 |
| Elovl1-3-7 (b) | 1.09 ± 0.05 | 0.91 ± 0.01 a,** | 0.97 ± 0.04 |
| Elovl1-3-7 (c) | 1.49 ± 0.06 | 1.34 ± 0.03 a,* | 1.33 ± 0.01 a,* |
| Elovl5 (n-6) | 0.29 ± 0.01 | 0.23 ± 0.00 a,*** | 0.22 ± 0.00 a,*** |
| Elovl2-5 (n-6) | 0.34 ± 0.00 | 0.31 ± 0.01 a,*** | 0.30 ± 0.01 a,*** |
| Elovl2-5 (n-3) | 3.76 ± 0.07 | 3.30 ± 0.18 a,* | 3.11 ± 0.12 a,** |
| Elovl2 (n-3) | 0.31 ± 0.01 | 0.30 ± 0.01 | 0.34 ± 0.01 |
| Peroxisomal | 10.39 ± 0.44 | 9.42 ± 0.15 | 8.91 ± 0.28 a,** |
Abbreviations: ACL, average chain length; SFA, saturated fatty acids; UFA, unsaturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids, and from n-3 and n-6 series (PUFAn-3 and PUFAn-6). Calculations: ACL = [(Σ% Total 14 × 14) + (Σ% Total 16 × 16) + (Σ% Total 18 × 18) + (Σ% Total 20 × 20) + (Σ% Total 22 × 22) + (Σ% Total 24 × 24)]/100. The density of double bonds in the membrane was calculated with the Double Bond Index. DBI = [(1 × Σ mol% monoenoic) + (2 × Σ mol% dienoic) + (3 × Σ mol% trienoic) + (4 × Σ mol% tetraenoic) + (5 × Σ mol% pentaenoic) + (6 × Σ mol% hexaenoic)]. Membrane susceptibility to peroxidation was calculated with the Peroxidizability Index. PI= [(0.025 × Σ mol% monoenoic) + (1 × Σ mol% dienoic) + (2 × Σ mol% trienoic) + (4 × Σ mol% tetraenoic) + (6 × Σ mol% pentaenoic) + (8 × Σ mol% hexaenoic)]. Elongase and desaturase activities were estimated from specific product/substrate ratios: delta-9-Desaturase (D9D) (n-7) = 16:1n-9/16:0; delta-9-Desaturase (D9D) (n-9) = 18:1n-9/18:0; delta-5-Desaturase (D5D) (n-6) = 20:4n-6/20:3n-6; delta-6-Desaturase (D6D) (n-3) (a) = 18:4n-3/18:3n-3; delta-6-Desaturase (D6D) (n-3) (b) = 24:6n-3/24:5n-3; Elovl3 (n-9) = 20:1n-9/18:1n-9; Elovl6 = 18:0/16:0; Elovl1-3-7 (a) = 20:0/18:0; Elovl1-3-7 (b) = 22:0/20:0; Elovl1-3-7 (c) = 24:0/22:0; Elovl5 (n-6) = 20:2n-6/18:2n-6; Elovl2-5 (n-6) = 22:4n-6/20:4n-6; Elovl2-5 (n-3) = 22:5n-3/20:5n-3, and Elovl2 (n-3)= 24:5n-3/22:5n-3. Finally, peroxisomal β-oxidation was estimated according to the ratio 22:6n-3/24:6n-3. Data are expressed as mean ± SEM. a comparison between aged and aged+MetR with the adult group. * p < 0.05, ** p < 0.01, *** p < 0.001. n (Adult) = 8, n (Aged) = 8, n (Aged+MetR) = 8.
Oxidation-derived protein damage markers in the rat cerebellum.
| Damage Marker | Adult | Aged | Aged+MetR |
|---|---|---|---|
| GSA | 5013.14 ± 144.38 | 4376.78 ± 116.83 a,* | 4410.87 ± 77.14 a,* |
| CEL | 579.82 ± 39.05 | 725.42 ± 93.56 | 660.52 ± 37.93 |
| CML | 1408.30 ± 59.83 | 1387.38 ± 105.08 | 1302.08 ± 43.07 |
| MDAL | 196.20 ± 8.66 | 179.29 ± 5.01 | 195.32 ± 8.66 |
| 2-SC | 39.79 ± 4.34 | 26.85 ± 1.80 a,* | 26.79 ± 2.27 a,* |
Abbreviations: GSA, glutamic semialdehyde; CEL, carboxyethyl-lysine; CML, carboxymethyl-lysine; MDAL, malondialdehyde lysine; 2-SC, 2-succinyl-cysteine. Data are expressed as mean ± SEM. a comparison between aged and aged + MetR with the adult group. * p < 0.05. Units: µmol/mol lysine. n (Adult) = 8, n (Aged) = 8, n (Aged+MetR) = 8.
Figure 2Multivariate analysis of the differential lipid species detected in the frontal cortex during aging and methionine restriction applied in old age. (A) Two-dimensional principal component analysis (PCA) for the different analyzed groups: adult, aged, and aged+MetR. (B) Heatmap of hierarchical clustering using the 25 lipid species with the lowest p-values. Each colored cell on the map corresponds to a relative concentration value, with samples in columns and compounds in rows. N (Adult) = 7, n (Aged) = 7, n (Aged+MetR) = 7.
Lipid species significantly different between experimental groups in the rat frontal cortex.
| Class | ID | Post Hoc | Biological Meaning (Biomarker) |
|---|---|---|---|
| FA | 12-hydroxyheptadecanoic acid b | Ag, R < A | aging |
| GL | TG (50:0) b | R < A | |
| TG (48:1) b | Ag, R < A | aging | |
| TG (54:6) b | Ag, R < A | aging | |
| TG (50:1) b | Ag, R < A | aging | |
| TG (64:14) b | A < Ag, R | aging | |
| TG (47:0) b | Ag < R | ||
| TG-O (58:10) a | R < Ag | ||
| DG (40:3) b | R < Ag | ||
| TG (64:14) a | A, Ag < R | MetR | |
| TG-O (60:9) b | R, A < Ag | healthy aging | |
| TG (62:12) b | Ag < R, A | healthy aging | |
| GP | PE (36:1) a | R < A | |
| PE (39:5)/PE-P (40:4) a | R < A | ||
| PC (36:2) a | Ag, R < A | aging | |
| PE-P (40:6) a | Ag, R < A | aging | |
| PE-P (38:6) a | Ag, R < A | aging | |
| PE-NMe (34:3)/PE (35:4)/PC (32:3) b | A, Ag < R | MetR | |
| PE-NMe (34:3)/PC (32:3) b | A, Ag < R | MetR | |
| PA (44:7) a | A, Ag < R | MetR | |
| PE (40:4) a | R < A, Ag | MetR | |
| PE (38:1) a | R < A, Ag | MetR | |
| PE-P (38:1) a | R < A, Ag | MetR | |
| PI (38:4) a | Ag < R, A | healthy aging | |
| PI (38:5) a | Ag < A | ||
| PG (34:1) a | Ag < R, A | healthy aging | |
| PL | Dolichol-20 d | A < Ag, R | aging |
| SP | Cer (36:1) a | Ag < A | |
| LacCer (34:2)/GalCer (44:2) b | R < A, Ag | MetR | |
| Cer (36:1) b | R < A, Ag | MetR | |
| N-(2R-Hydroxyhexadecanoyl)-2S-amino-9-methyl-4E,8E-octadecadiene-1,3R-diol b | R < A, Ag | MetR | |
| Cer (34:1) c | R < A, Ag | MetR | |
| SL | CE (20:4) b | A < Ag, R | aging |
| CE (5:0) b | A, Ag < R | MetR |
All compounds are putatively annotated compounds based upon physicochemical properties and/or spectral similarity with public/commercial spectral libraries [29]. a Identity (ID) based on exact mass, retention time (RT), and MS/MS spectrum; b ID based on exact mass and RT; c ID based on MS/MS spectrum; (d) ID based on exact mass. FA: fatty acyls, GL: glycerolipids, GP: glycerophospholipids, SP: sphingolipids, SL: sterol lipids. Ag: Aged, R: Aged+MetR, A: Adult, n.i: no information. n (Adult) = 7, n (Aged) = 7, n (Aged+MetR) = 7.
Fatty acid composition of total lipids in the rat frontal cortex [30].
| Fatty Acid | Adult | Aged | Aged+MetR |
|---|---|---|---|
| 14:0 | 0.92 ± 0.02 | 0.91 ± 0.01 | 0.92 ± 0.02 |
| 16:0 | 29.03 ± 0.014 | 29.31 ± 0.26 | 28.83 ± 0.12 |
| 16:1n-7 | 0.54 ± 0.02 | 0.56 ± 0.03 | 0.52 ± 0.01 |
| 18:0 | 24.17 ± 0.23 | 24.19 ± 0.11 | 24.20 ± 0.10 |
| 18:1n-9 | 19.71 ± 0.26 | 19.18 ± 0.19 | 19.47 ± 0.20 |
| 18:2n-6 | 0.94 ± 0.02 | 1.00 ± 0.03 | 1.06 ± 0.06 |
| 18:3n-6 | 0.03 ± 0.00 | 0.04 ± 0.00 | 0.04 ± 0.00 |
| 18:3n-3 | 0.03 ± 0.00 | 0.04 ± 0.00 | 0.04 ± 0.00 |
| 18:4n-3 | 0.04 ± 0.00 | 0.04 ± 0.00 | 0.05 ± 0.00 |
| 20:0 | 0.18 ± 0.01 | 0.18 ± 0.01 | 0.19 ± 0.01 |
| 20:1n-9 | 0.71 ± 0.04 | 0.68 ± 0.04 | 0.71 ± 0.04 |
| 20:2n-6 | 0.11 ± 0.00 | 0.11 ± 0.00 | 0.12 ± 0.01 |
| 20:3n-6 | 0.20 ± 0.00 | 0.22 ± 0.01 | 0.24 ± 0.01 a,*** |
| 20:4n-6 | 10.20 ± 0.26 | 10.49 ± 0.11 | 10.53 ± 0.18 |
| 20:5n-3 | 0.04 ± 0.00 | 0.04 ± 0.00 | 0.04 ± 0.00 |
| 22:0 | 0.18 ± 0.01 | 0.16 ± 0.01 | 0.16 ± 0.00 |
| 22:1n-9 | 0.57 ± 0.05 | 0.58 ± 0.03 | 0.62 ± 0.02 |
| 22:4n-6 | 2.38 ± 0.08 | 2.35 ± 0.05 | 2.35 ± 0.07 |
| 22:5n-6 | 0.80 ± 0.07 | 0.99 ± 0.09 | 0.91 ± 0.08 |
| 22:5n-3 | 0.09 ± 0.00 | 0.10 ± 0.00 | 0.10 ± 0.00 |
| 22:6n-3 | 7.95 ± 0.25 | 8.31 ± 0.19 | 8.36 ± 0.17 |
| 24:0 | 0.15 ± 0.01 | 0.17 ± 0.00 | 0.17 ± 0.01 |
| 24:1 | 0.17 ± 0.01 | 0.14 ± 0.01 | 0.14 ± 0.01 |
| 24:5n-3 | 0.04 ± 0.00 | 0.04 ± 0.00 | 0.04 ± 0.00 |
| 24:6n-3 | 0.19 ± 0.01 | 0.15 ± 0.00 a,* | 0.15 ± 0.01 a,** |
Data are expressed as mean ± SEM. a Comparison between aged and aged+MetR with the adult group. * p < 0.05, ** p < 0.01, *** p < 0.001. n (Adult) = 8, n (Aged) = 8, n (Aged+MetR) = 8.
Calculated indices from the fatty acid profile in the rat frontal cortex.
| Fatty Acid Index | Adult | Aged | Aged+MetR |
|---|---|---|---|
| ACL | 18.12 ± 0.01 | 18.13 ± 0.01 | 18.12 ± 0.02 |
| SFA | 54.63 ± 0.19 | 54.89 ± 0.35 | 54.45 ± 0.15 |
| UFA | 44.67 ± 0.58 | 45.09 ± 0.34 | 45.43 ± 0.16 |
| MUFA | 21.77 ± 0.33 | 21.15 ± 0.25 | 21.40 ± 0.27 |
| PUFA | 23.05 ± 0.58 | 23.94 ± 0.30 | 24.03 ± 0.33 |
| PUFAn-3 | 8.57 ± 0.17 | 8.74 ± 0.18 | 8.78 ± 0.17 |
| PUFAn-6 | 14.67 ± 0.36 | 15.20 ± 0.19 | 15.25 ± 0.27 |
| DBI | 128.67 ± 2.74 | 132.49 ± 1.52 | 132.94 ± 1.43 |
| PI | 123.50 ± 3.31 | 128.55 ± 1.91 | 128.69 ± 1.97 |
| D9D (n-7) | 0.02 ± 0.00 | 0.02 ± 0.00 | 0.02 ± 0.00 |
| D9D (n-9) | 0.82 ± 0.01 | 0.79 ± 0.01 | 0.80 ± 0.01 |
| D5D (n-6) | 49.68 ± 0.31 | 47.75 ± 2.05 | 43.81 ± 1.12 a,* |
| D6D (n-3) (a) | 1.03 ± 0.16 | 1.10 ± 0.07 | 1.18 ± 0.06 |
| D6D (n-3) (b) | 5.10 ± 0.55 | 3.88 ± 0.34 a,* | 3.86 ± 0.36 |
| Elovl3 (n-9) | 0.04 ± 0.00 | 0.04 ± 0.00 | 0.04 ± 0.00 |
| Elovl6 | 0.83 ± 0.01 | 0.83 ± 0.00 | 0.84 ± 0.01 |
| Elovl1-3-7 (a) | 0.01 ± 0.00 | 0.01 ± 0.00 | 0.01 ± 0.00 |
| Elovl1-3-7 (b) | 1.02 ± 0.04 | 0.86 ± 0.03 a,** | 0.86 ± 0.02 a,** |
| Elovl1-3-7 (c) | 0.85 ± 0.05 | 1.01 ± 0.15 | 1.07 ± 0.08 |
| Elovl5 (n-6) | 0.12 ± 0.00 | 0.11 ± 0.00 | 0.11 ± 0.00 |
| Elovl2-5 (n-6) | 0.23 ± 0.00 | 0.22 ± 0.00 | 0.22 ± 0.01 |
| Elovl2-5 (n-3) | 2.76 ± 0.22 | 2.65 ± 0.15 | 2.43 ± 0.14 |
| Elovl2 (n-3) | 0.41 ± 0.03 | 0.40 ± 0.02 | 0.42 ± 0.03 |
| Peroxisomal | 43.85 ± 3.05 | 54.04 ± 2.12 a,* | 56.40 ± 1.92 a,** |
For details, see Table 3. Data are expressed as mean ± SEM. a comparison between aged and aged+MetR with the adult group. * p < 0.05, ** p < 0.01. n (Adult) = 8, n (Aged) = 8, n (Aged+MetR) = 8.
Oxidation-derived protein damage markers in the rat frontal cortex.
| Damage Marker | Adults | Aged | Aged+MetR |
|---|---|---|---|
| GSA | 3615.40 ± 79.03 | 3700.19 ± 138.23 | 3623.83 ± 246.00 |
| CEL | 270.70 ± 15.58 | 259.79 ± 29.33 | 233.04 ± 11.36 |
| CML | 966.24 ± 40.79 | 1016.19 ± 63.22 | 949.69 ± 85.01 |
| MDAL | 372.59 ± 30.48 | 345.74 ± 6.80 | 376.28 ± 21.86 |
| 2-SC | 28.43 ± 4.18 | 20.78 ± 2.28 | 35.55 ± 4.99 b,* |
For details, see Table 4. Data are expressed as mean ± SEM. b comparison between aged and aged+MetR groups. * p < 0.05. Units: µmol/mol lysine. n (Adult) = 7, n (Aged)= 8, n (Aged+MetR) = 8.